✓ Last verified: January 25, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: The Schulte Institute in Scottsdale, Arizona is led by Dr. H. Jim Schulte and provides ketamine therapy as part of a comprehensive psychiatric and pain management practice. Their Scottsdale location offers patients in the Phoenix metropolitan area access to ketamine treatments administered by an experienced physician in a well-established clinical setting.
| Review Scores | 4.6 stars |
| Location | Scottsdale, Arizona |
| Address | 7101 E. Indian School Rd., Scottsdale, AZ 85251 |
| Phone | (480) 941-9004 |
| Website | drhjimschulte.com |
| Treatments | IV Ketamine Infusions, Psychiatric Services |
| Conditions Treated | Depression, Anxiety, PTSD, Chronic Pain, Bipolar Disorder |
| Cost | Contact for pricing |
| Insurance | Contact for details |
| KAP Available? | Contact for details |
| Clinical Lead | Dr. H. Jim Schulte |
HealingMaps Take: The Schulte Institute offers physician-led ketamine therapy in central Scottsdale, combining ketamine treatments with broader psychiatric expertise. Dr. Schulte’s established practice and Indian School Road location make this a convenient and credible option for patients across the Phoenix metro area seeking ketamine therapy from an experienced clinician.
Market Position: The Schulte Institute is a verified ketamine provider in the Scottsdale metro on HealingMaps — one of 1,473 clinics we have mapped and tracked across 3,142 U.S. counties.
Industry pricing reference. The Schulte Institute has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine Infusion | $350–$650/session | ✓ |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with integrated talk therapy) | $400–$1,200/session | — |
| At-home oral troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Maricopa County, AZ, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
44.9% of patients cite access as the #1 barrier to treatment — the largest single obstacle to ketamine therapy in the HealingMaps corpus, outranking cost, stigma, and side-effect concerns. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 4-question summary is matched to the protocols and conditions The Schulte Institute treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
The Schulte Institute treats depression via IV ketamine (off-label, evidence-based). Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — The Schulte Institute treats chronic pain. They use IV ketamine for pain, which typically means longer infusion times and higher cumulative doses than mental-health protocols. Common indications include complex regional pain syndrome (CRPS), fibromyalgia, and certain neuropathic pain syndromes. Pain pricing varies significantly by structure: per-infusion vs. multi-day inpatient packages — verify how this clinic structures their billing.
Yes — The Schulte Institute treats PTSD. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — The Schulte Institute treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply